A proteomic investigation of similarities between conventional and herbal antidepressant treatments

Journal of Psychopharmacology

Volumn 23, Issue 5, 2009, Pages 520-530

  Pennington, K ^a,d   Focking M ^a   McManus, C A ^b   Pariante, C M ^c   Dunn, M J ^b   Cotter, D R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

2 DE; Antidepressants; Chinese herbal medicine; Clomipramine; Neuronal plasticity; St Johns wort

Indexed keywords

CLOMIPRAMINE; CYTOSKELETON PROTEIN; HYPERICUM PERFORATUM EXTRACT; PLANT MEDICINAL PRODUCT; PROTEOME; UNCLASSIFIED DRUG; XIAO YAO SAN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL LINE; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; CYTOTOXICITY; ENERGY METABOLISM; HERBAL MEDICINE; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL LINE; CLOMIPRAMINE; CYTOSKELETON; DRUGS, CHINESE HERBAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPERICUM; MASS SPECTROMETRY; MICE; PROTEOMICS; VIMENTIN;

EID: 67449152751     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108091075     Document Type: Article

References (51)

1. Alban A., David SO., Bjorkesten L., Andersson C., Sloge E., Lewis S., (2003) A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3: 36-44. (Pubitemid 36151066)
2. Beasley CL., Pennington K., Behan A., Wait R., Dunn MJ., Cotter D., (2006) Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 6: 3414-3425. (Pubitemid 43886157)
3. Behl C., Davis J., Cole GM., Schubert D., (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 186: 944-950.
4. Behl C., Widmann M., Trapp T., Holsboer F., (1995) 17-Beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216: 473-482.
5. Bradford MM., (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
6. Carboni L., Vighini M., Piubelli C., Castelletti L., Milli A., Domenici E., (2006) Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. Eur Neuropsychopharmacol 16: 521-537. (Pubitemid 44376555)
7. Castilla A., Subira ML., Civeira MP., Cuende JI., Prieto J., (1992) Monocytic dysfunction by opioid peptides in patients with major depression. Med Clin (Barc) 99: 241-243.
8. Cecconi D., Mion S., Astner H., Domenici E., Righetti PG., Carboni L., (2007) Proteomic analysis of rat cortical neurons after fluoxetine treatment. Brain Res 1135: 41-51. (Pubitemid 46176819)
9. Chen B., Wang JF., Sun X., Young LT., (2003) Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells. Biol Psychiatry 53: 530-537. (Pubitemid 36331892)
10. Conti B., Maier R., Barr AM., Morale MC., Lu X., Sanna PP., (2007) Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 12: 167-189. (Pubitemid 46160982)
11. DSa C., Duman RS., (2002) Antidepressants and neuroplasticity. Bipolar Disord 4: 183-194. (Pubitemid 34591244)
12. Duman RS., Nakagawa S., Malberg JE., (2001) Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25: 836-844. (Pubitemid 34031890)
13. Ernst E., Rand JI., Stevinson C., (1998) Complementary therapies for depression: an overview. Arch Gen Psychiatry 55: 1026 - 1032. (Pubitemid 28506845)
14. Focking M., Boersema PJ., ODonoghue N., Lubec G., Pennington SR., Cotter DR., (2006) 2-D DIGE as a quantitative tool for investigating the HUPO Brain Proteome Project mouse series. Proteomics 6: 4914-4931. (Pubitemid 44483888)
15. Fugh-Berman A., (2000) Herb-drug interactions. Lancet 355: 134-138. (Pubitemid 30068565)
16. Gaster B., Holroyd J., (2000) St Johns wort for depression: a systematic review. Arch Intern Med 160: 152-156. (Pubitemid 30054333)
17. Guest PC., Knowles MR., Molon-Noblot S., Salim K., Smith D., Murray F., (2004) Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling. Brain Res 1002: 1-10. (Pubitemid 38251573)
18. Hall SD., Wang Z., Huang SM., Hamman MA., Vasavada N., Adigun AQ., (2003) The interaction between St Johns wort and an oral contraceptive. Clin Pharmacol Ther 74: 525-535. (Pubitemid 37521996)
19. Harrison PJ., (2004) The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174: 151-162. (Pubitemid 38925100)
20. Herr AS., Tsolakidou AF., Yassouridis A., Holsboer F., Rein T., (2003) Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology 78: 12-22. (Pubitemid 36921030)
21. Hrdina PD., Dubas TC., (1981) Brain distribution and kinetics of desipramine in the rat. Can J Physiol Pharmacol 59: 163 - 167. (Pubitemid 11152381)
22. Kasper S., Anghelescu IG., Szegedi A., Dienel A., Kieser M., (2006) Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]. BMC Med 4: 14.
23. Kessler RC., Soukup J., Davis RB., Foster DF., Wilkey SA., Van Rompay MI., (2001) The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry 158: 289-294. (Pubitemid 32116527)
24. Khawaja X., Xu J., Liang JJ., Barrett JE., (2004) Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res 75: 451-460. (Pubitemid 38160706)
25. Knuuttila JE., Toronen P., Castren E., (2004) Effects of antidepressant drug imipramine on gene expression in rat prefrontal cortex. Neurochem Res 29: 1235-1244. (Pubitemid 39023497)
26. Landgrebe J., Welzl G., Metz T., van Gaalen MM., Ropers H., Wurst W., (2002) Molecular characterisation of antidepressant effects in the mouse brain using gene expression profiling. J Psychiatr Res 36: 119-129. (Pubitemid 34218952)
27. Lee KH., Ahn JI., Yu DH., Koh HC., Kim SH., Yang BH., (2003) Dextromethorphan alters gene expression in rat brain hippocampus and cortex. Int J Mol Med 11: 559-568.
28. Lendahl U., McKay RD., (1990) The use of cell lines in neurobiology. Trends Neurosci 13: 132-137. (Pubitemid 20102529)
29. Linde K., Berner M., Egger M., Mulrow C., (2005) St Johns wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry 186: 99-107. (Pubitemid 40193777)
30. Malberg JE., Eisch J., Nestler EJ., Duman RS., (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110. (Pubitemid 32042912)
31. Manji HK., Drevets WC., Charney DS., (2001) The cellular neurobiology of depression. Nat Med 7: 541-547. (Pubitemid 32448319)
32. McHugh PC; .,Rogers GR; .,Loudon B; .,Glubb DM; .,Joyce PR; .,Kennedy MA; ., (2008) Proteomic analysis of embryonic stem cell-derived neural cells exposed to the antidepressant paroxetine. J Neurosci Res 86: 306-316. (Pubitemid 351196736)
33. Miller BH., Schultz LE., Gulati A., Cameron MD., Pletcher MT., (2008) Genetic regulation of behavioral and neuronal responses to fluoxetine. Neuropsychopharmacology 33: 1312-1322.
34. Morimoto BH., Koshland DE Jr., (1990) Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line. Neuron 5: 875-880.
35. Pariante CM., Hye A., Williamson R., Makoff A., Lovestone S., Kerwin RW., (2003a) The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones. Neuropsychopharmacology 28: 1553-1561. (Pubitemid 41070855)
36. Pariante CM., Kim RB., Makoff A., Kerwin RW., (2003b) Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br J Pharmacol 139: 1111-1118. (Pubitemid 36920673)
37. Pariante CM., Makoff A., Lovestone S., Feroli S., Heyden A., Miller AH., (2001) Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol 134: 1335-1343. (Pubitemid 33097265)
38. Pariante CM., Pearce BD., Pisell TL., Owens MJ., Miller AH., (1997) Steroid-independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol Pharmacol 52: 571-581. (Pubitemid 27443978)
39. Paul IA., Skolnick P., (2003) Glutamate and depression: clinical and preclinical studies. Ann N Y Acad Sci 1003: 250-272. (Pubitemid 38083061)
40. Pennington K., Beasley CL., Dicker P., Fagan A., English J., Pariante CM., (2007) Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry Oct.16; [Epub ahead of print].
41. Perloff MD., von Moltke LL., Stormer E., Shader RI., Greenblatt DJ., (2001) Saint Johns wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 134: 1601-1608. (Pubitemid 34038092)
42. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., (2003) Requirement of hippocampal neurogenesis for the behavioural effects of antidepressants. Science 301: 805-809. (Pubitemid 36962615)
43. Sheline YI., Gado MH., Kraemer HC., (2003) Untreated depression and hippocampal volume loss. Am J Psychiatry 160: 1516 - 1518. (Pubitemid 41070930)
44. Sheline YI., Wang PW., Gado MH., Csernansky JG., Vannier MW., (1996) Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 93: 3908-3913. (Pubitemid 26144221)
45. Williams JW Jr., Mulrow CD., Chiquette E., Noel PH., Aguilar C., Cornell J., (2000) A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 132: 743-756. (Pubitemid 30244176)
46. Wong ML., OKirwan F., Hannestad JP., Irizarry KJ., Elashoff D., Licinio J., (2004) St Johns wort and imipramine-induced gene expression profiles identify cellular functions relevant to antidepressant action and novel pharmacogenetic candidates for the phenotype of antidepressant treatment response. Mol Psychiatry 9: 237-251. (Pubitemid 38496714)
47. Yan JX., Wait R., Berkelman T., Harry RA., Westbrook JA., Wheeler CH., (2000) A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 21: 3666-3672.
48. Zarate CA Jr., Du J., Quiroz J., Gray NA., Denicoff KD., Singh J., (2003) Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann N Y Acad Sci 1003: 273-291. (Pubitemid 38083062)
49. Zhang ZJ., Kang WH., Li Q., Tan QR., (2007a) The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies. J Psychiatr Res 41: 828-836. (Pubitemid 46693897)
50. Zhang ZJ., Kang WH., Tan QR., Li Q., Gao CG., Zhang FG., (2007b) Adjunctive herbal medicine with carbamazepine for bipolar disorders: a double-blind, randomized, placebo-controlled study. J Psychiatr Res 41: 360-369. (Pubitemid 44854983)
51. Zhang LD., Zhang YL., Xu SH., Zhou G., Jin SB., (1994) Traditional Chinese medicine typing of affective disorders and treatment. Am J Chin Med 22: 321-327.